drugset / Trial / NCT03833895

The Phenylephrine vs. Norepinephrine Infusion Undergoing Cesarean Section

NCT03833895

Phase 2/3 Completed 238 enrolled China International Neuroscience Institution
RandomizedParallel-groupTriple-blindSupportive care

Summary

Compare 0.05 μg/kg/min Norepinephrine and 0.25 μg/kg/min phenylephrine effect on fetus and parturient during Cesarean Section

Timeline

Start
2019-02-20
Primary completion
2019-09-01
Completion
2019-09-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Norepinephrine Other / unclassified 0.05 ug/kg
Subject Phenylephrine Small molecule 0.25 ug/kg

Indications

No indication recorded.